Nextstellis (Drospirenone and Estetrol)
- Medicine Name: Nextstellis
- Generic Name: Drospirenone and Estetrol
- Dosage Form & Strength: 28 Tablets: 3 mg/14.2 mg
- Manufactured By: Mayne Pharma US
Medical Uses
Medical Uses: Nextstellis is the first and only FDA-approved combination (drospirenone, a progestin, and estetrol, an estrogen) oral birth control pill used to prevent pregnancy. It is the first oral contraceptive to contain E4. The E4 in this medicine is produced from a plant source and has selective actions in tissues. It supports the health of the uterus, vagina, and bones. It has a minimal impact on the liver and breast tissue.
Note: Nextstellis may be less effective if females have a body mass index (BMI) of 30 or beyond. It is not known if this medication is safe and effective in females with a body mass index (BMI) of 35 or beyond.
Recommended Dosage: The recommended dose is one pill, once daily for 28 successive days: one pink active tablet daily during the initial 24 days followed by one white inactive tablet daily during the four following days. Take tablets by mouth at the same time each day with or without food.
In case of puking or acute diarrhea (within 3 to 4 hours) after taking an active pill, take the new active pill as promptly as possible. Take the new pill within 12 hours of the standard time of pill-taking if possible. If over 2 tablets are missed, follow the suggestion concerning missed dosage, including considering backup non-hormonal contraception.
Warning & Precautions
- Prior to initiating drospirenone and estetrol, assess any known medical history or family history of thromboembolic or thrombotic disorders. Women with a greater risk of arterial or venous thrombotic or thromboembolic diseases should avoid the use of this medicine.
- Use of Nextstellis 3 mg/14.2 mg is not recommended in women with uncontrolled hypertension or hypertension with vascular complications. For all women, including those with well-controlled hypertension, assess blood pressure periodically and halt the treatment if there is a significant rise in blood pressure.
- This medicinal product is contraindicated in women who have migraines with aura. Discontinue treatment with Nextstellis in women using this drug who develop recurrent, persistent, or severe migraines. Discontinue treatment if there is an increased severity and frequency of migraines during the use of CHC.
- Nextstellis is not for females with current or a history of hormonally-sensitive malignancies (e.g., breast cancer). Discontinue treatment in case the diagnosis of hormonally-sensitive malignancy occurred. This medicine may promote the growth of any hormone receptor-positive tumor, both within and outside the female reproductive tract.
- Females with acute hepatitis or severe (decompensated) cirrhosis should avoid using Nextstellis. Hold over or permanently discontinue this therapy for the persistent or significant elevation of liver enzymes. This medicinal product can be responsible for causing elevated liver enzymes.
- Women with Nextstellis tablets may face unscheduled bleeding as well as spotting, mainly during the initial four months of treatment. Individuals may overcome bleeding irregularities over time or by changing to another contraceptive. In case bleeding persists or occurs following previously regular cycles, reasons (pregnancy or malignancy) should be evaluated.
Documentation & Availability
What documents are required to import NEXTSTELLIS to India?
NEXTSTELLIS (Drospirenone and Estetrol) Tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is NEXTSTELLIS available in India?
NEXTSTELLIS (Drospirenone and Estetrol Tablet) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
NEXTSTELLIS can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit
S S Healthcare (S S Healthcare) can facilitate the supply of NEXTSTELLIS (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Number: +91-7575883015 or write us at sshealthcare1012@gmail.com for Nextstellis tablets price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the NEXTSTELLIS (Cancer Treatment Medicines) from across the globe and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Nextstellis®?
Drospirenone and Estetrol is a Generic Name for the trade name drug Nextstellis®.
What is the Manufacturer’s Name of Nextstellis®?
Nextstellis® is manufactured by Mayne Pharma US.
Is Nextstellis® approved by the FDA?
Yes, Nextstellis® is approved by the FDA. Date of first/initial approval: April 15, 2021.
Is S S Healthcare WHO-GDP and ISO 9001 2015 Certified?
Yes, S S Healthcare is WHO-GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler, Exporter, Importer, and Nextstellis supplier in India.
What is the dosage and form of Nextstellis® supplied?
Nextstellis® is supplied as 28 Tablets for oral administration in the following order:
- 24 pink active tablets each containing 3 mg drospirenone and 14.2 mg estetrol
- 4 white inert tablets
Where can I get Nextstellis® at the best price in India?
To get the best Nextstellis price in India, kindly contact S S Healthcare (a WHO GDP & ISO 9001:2008 certified company). For Nextstellis®, a valid medical prescription is required from your treating physician.
What are the most common side effects of Nextstellis®?
The most common side effects of Nextstellis® are mood disturbance, headache, bleeding irregularities, acne, breast symptoms, dysmenorrhea, libido decreased, and weight increased.
How much does Nextstellis cost in India?
The Nextstellis cost in India can vary. In order to procure Nextstellis Tablets authentically, you can Call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Nextstellis®?
Nextstellis comes in cardboard cartons containing 1 blister card of 28 tablets. Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F).
Is it safe to buy Nextstellis® online in India?
Yes, you can buy Nextstellis in India at the best price from the S S Healthcare if the drug Nextstellis has not been approved or is not available in your home country.
What are the Highlights of prescribing information for Nextstellis®?
Click Here to download full Nextstellis prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
